Details for New Drug Application (NDA): 213105
✉ Email this page to a colleague
The generic ingredient in CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for 213105
Tradename: | CETIRIZINE HYDROCHLORIDE ALLERGY |
Applicant: | Catalent |
Ingredient: | cetirizine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 213105
Mechanism of Action | Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 213105
Suppliers and Packaging for NDA: 213105
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 213105 | ANDA | L. Perrigo Company | 0113-0981 | 0113-0981-63 | 1 BOTTLE in 1 CARTON (0113-0981-63) / 25 CAPSULE, LIQUID FILLED in 1 BOTTLE |
CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 213105 | ANDA | Rite Aid Corporation | 11822-0980 | 11822-0980-0 | 1 BOTTLE in 1 PACKAGE (11822-0980-0) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
Approval Date: | Sep 21, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription